Coherus Oncology
CA - Redwood CityBiotechnology
Focus: Coherus Oncology is a mid-cap biotech focused on oncology biologics and biosimilars, headquartered in Redwood City, CA with a diversified pipeline spanning immuno-oncology, cell therapy, and biosimilar development. The company operates as a public entity (NASDAQ: CHRS) with recent Q2 2026 results showing growing LOQTORZI revenue despite reported losses.
Profile data last refreshed 4h ago · AI intelligence enriched 2w ago
Open Jobs
5-1 this month
Stable — net -1 jobs in 30d
2 added, 3 removed. Backfill posture.
Should You Work at Coherus Oncology?
AI assessmentCoherus offers solid exposure to diversified oncology innovation and commercial experience, but near-term financial headwinds and limited hiring velocity make it a better fit for risk-tolerant candidates seeking deep pipeline exposure over rapid career scaling.
Why Work Here
- Diverse pipeline of 27 active programs across Phase 1–4, with multiple Phase 2/3 assets (Toripalimab, Etanercept, CHS-0214) offering near-term clinical catalysts and learning opportunities in oncology and immunology
Data completeness
4/9 — Basic
Company HealthStrong
Pipeline
Late-stage
4 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Slowing
Jobs decreasing
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Pegfilgrastim-Cbqv
Febrile NeutropeniaClinical Trials (1)
NCT04662892An Analysis to Estimate Febrile Neutropenia (FN) in Patients Receiving Udenyca
N/AHelp build intelligence for Coherus Oncology
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.